Updated Jul 16, 2026
Gould Robert J has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $507K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-04 | FULC | Fulcrum Therapeutics, Inc. | S — Open-market sale [10b5-1] | 15.0K | $10.87 | $163K |
| 2026-01-06 | FULC | Fulcrum Therapeutics, Inc. | S — Open-market sale [10b5-1] | 15.0K | $11.87 | $178K |
| 2025-11-21 | FULC | Fulcrum Therapeutics, Inc. | S — Open-market sale [10b5-1] | 15.0K | $11.03 | $165K |
Gould Robert J is a corporate insider — currently tracked as Insider of Fulcrum Therapeutics, Inc. (FULC). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($507K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gould Robert J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.